212 related articles for article (PubMed ID: 33816230)
1. HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.
Liu C; Zhou X; Zeng H; Wu D; Liu L
Front Oncol; 2021; 11():597860. PubMed ID: 33816230
[No Abstract] [Full Text] [Related]
2. TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs.
Wang K; Feng X; Zheng L; Chai Z; Yu J; You X; Li X; Cheng X
Front Mol Biosci; 2021; 8():690500. PubMed ID: 34262942
[No Abstract] [Full Text] [Related]
3. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
4. CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis.
Guo L; Li B; Lu Z; Liang H; Yang H; Chen Y; Zhu S; Zeng M; Wei Y; Liu T; Jiang T; Xuan M; Tang H
Front Mol Biosci; 2021; 8():674863. PubMed ID: 34055889
[TBL] [Abstract][Full Text] [Related]
5. High expression of HILPDA is an adverse prognostic prognostic factor in hepatocellular carcinoma.
Wang X; Zou A; Zhang J; Gao G; Shan W; Li J; Liu X
Medicine (Baltimore); 2023 Mar; 102(9):e33145. PubMed ID: 36862910
[TBL] [Abstract][Full Text] [Related]
6. FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.
Zhong A; Chen T; Xing Y; Pan X; Shi M
Front Immunol; 2021; 12():758648. PubMed ID: 34745134
[TBL] [Abstract][Full Text] [Related]
7. A pan-cancer analysis of RNASEH1, a potential regulator of the tumor microenvironment.
Yi C; Yang J; Zhang T; Xie S; Li W; Qin L; Chen D
Clin Transl Oncol; 2023 Aug; 25(8):2569-2586. PubMed ID: 37022517
[TBL] [Abstract][Full Text] [Related]
8. ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer.
Jia Z; Wan X
Front Cell Dev Biol; 2022; 10():792564. PubMed ID: 35237596
[No Abstract] [Full Text] [Related]
9. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
10.
Zhao K; Yi Y; Ma Z; Zhang W
Front Genet; 2021; 12():705512. PubMed ID: 35058963
[No Abstract] [Full Text] [Related]
11. P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer.
Zhao Q; Liu J
Front Cell Dev Biol; 2021; 9():754580. PubMed ID: 34966739
[No Abstract] [Full Text] [Related]
12. A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
Wang K; Guan C; Shang X; Ying X; Mei S; Zhu H; Xia L; Chai Z
Aging (Albany NY); 2021 Mar; 13(5):7416-7429. PubMed ID: 33686968
[TBL] [Abstract][Full Text] [Related]
13. TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma.
Zhong A; Chen T; Zhou T; Zhang Z; Shi M
Front Pharmacol; 2021; 12():728420. PubMed ID: 34744715
[TBL] [Abstract][Full Text] [Related]
14. SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer.
Huang Y; You M; Wu Q; Zhu W; Guo F; Lin W
Ann Clin Lab Sci; 2022 Nov; 52(6):904-917. PubMed ID: 36564070
[TBL] [Abstract][Full Text] [Related]
15. Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis.
Zhao G; Song D; Wu J; Yang S; Shi S; Cui X; Ren H; Zhang B
Front Immunol; 2022; 13():955091. PubMed ID: 36052059
[TBL] [Abstract][Full Text] [Related]
16. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X
BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and immunological role of SERPINH1 in pan-cancer.
Zhong H; Wang Z; Wei X; Liu Y; Huang X; Mo X; Tang W
Front Genet; 2022; 13():900495. PubMed ID: 36105106
[No Abstract] [Full Text] [Related]
18. Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice.
Maier A; Wu H; Cordasic N; Oefner P; Dietel B; Thiele C; Weidemann A; Eckardt KU; Warnecke C
FASEB J; 2017 Nov; 31(11):4971-4984. PubMed ID: 28760743
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of the Oncogenic and Immunological Role of
Ding J; Meng Y; Han Z; Luo X; Guo X; Li Y; Liu S; Zhuang K
Front Oncol; 2022; 12():811567. PubMed ID: 35651805
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin, a potential coregulator of immune checkpoints and biomarker associated with tumor microenvironment and clinical prognostic significance in breast invasive carcinoma.
Lin J; Chen Y; Zhang Z; Qi F; Zhang M
Environ Toxicol; 2024 May; 39(5):2717-2731. PubMed ID: 38247288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
